By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anticholinergic bronchodilators > Spiriva respimat 10 act > Tiotropium Dosage
Anticholinergic bronchodilators
https://themeditary.com/dosage-information/tiotropium-dosage-11435.html

Tiotropium Dosage

Drug Detail:Spiriva respimat 10 act (Tiotropium inhalation [ tye-oh-troe-pee-um ])

Drug Class: Anticholinergic bronchodilators

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance

Tiotropium inhalation powder, hard capsule:

  • 18 mcg (2 inhalations) orally once a day using the HandiHaler device

Tiotropium, solution for inhalation:
  • 5 mcg (2 inhalations) orally once a day

Uses: Long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema; to reduce exacerbations in COPD patients

Usual Adult Dose for Asthma - Maintenance

  • 2.5 mcg (2 inhalations of 1.25 mcg) orally once a day

Comments:
  • The maximum benefits in lung function may take up to 4 to 8 weeks of dosing.

Use: Long-term maintenance treatment of asthma

Usual Pediatric Dose for Asthma - Maintenance

6 years or older:

  • 2.5 mcg (2 inhalations of 1.25 mcg) orally once a day

Comments:
  • The maximum benefits in lung function may take up to 4 to 8 weeks of dosing.

Use: Long-term maintenance treatment of asthma

Renal Dose Adjustments

Mild renal dysfunction (CrCl 60 mL/min or more): No adjustment recommended.
Moderate to Severe renal dysfunction (CrCl less than 60 mL/min): Use with caution.

Liver Dose Adjustments

No adjustment recommended.

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to any of the ingredients

COPD: Safety and efficacy have not been established in patients younger than 18 years.
Asthma: Safety and efficacy have not been established in patients younger than 6 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Tiotropium inhalation spray should be administered only via the Respimat inhaler and it should not be used for administering other medications.
  • Tiotropium capsules are for oral inhalation only and should not be swallowed; capsules should be used with the HandiHaler device only.
  • Priming the inhalation device is essential to ensure appropriate content of the medication in each actuation.
  • Consult the manufacturer's product information for complete administration instructions.

General:
  • This drug should not be used for the initial treatment of acute episodes of bronchospasm, or for immediate relief of breathing problems (i.e., as a rescue medication).

Patient advice:
  • Patients should report any signs and symptoms of narrow angle glaucoma (e.g., eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema) and urinary retention (e.g., difficulty passing urine, painful urination).
  • Patients should avoid getting this drug into the eyes as it may cause blurring of vision and pupil dilation.
  • This drug may cause dizziness and blurred vision; avoid driving or operating machinery if you feel drowsy or dizzy.
  • Advise patients that anaphylaxis, angioedema (including swelling of the lips, tongue, or throat), urticaria, rash, bronchospasm, or itching may occur with this medication, and to immediately discontinue treatment and consult a physician if these signs or symptoms develop.
Share this Article
Latest News
Medical News

Obesity, unhealthy lifestyles may cause heart to age by 5–45 years

May 08, 2025
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Heart disease: Just 3 minutes of 'incidental activity' may lower...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by